These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 24456273)

  • 1. An overview of phytotherapeutic approaches for the treatment of benign prostatic hyperplasia.
    Aggarwal S; Verma A; Shukla R; Batra S; Bhardwaj TR; Kumar M
    Mini Rev Med Chem; 2014; 14(3):257-70. PubMed ID: 24456273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview.
    Sharma M; Chadha R; Dhingra N
    Mini Rev Med Chem; 2017; 17(14):1346-1363. PubMed ID: 27337973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors.
    Elterman DS; Lawrentschuk N; Guns E; Hersey K; Adomat H; Wood CA; Fleshner N
    J Urol; 2010 May; 183(5):2085-9. PubMed ID: 20303529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytotherapy in the management of benign prostatic hyperplasia.
    Lowe FC
    Urology; 2001 Dec; 58(6 Suppl 1):71-6; discussion 76-7. PubMed ID: 11750257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia.
    Dreikorn K
    World J Urol; 2002 Apr; 19(6):426-35. PubMed ID: 12022711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytotherapeutic agents in the treatment of benign prostatic hyperplasia.
    Dreikorn K
    Curr Urol Rep; 2000 Aug; 1(2):103-9. PubMed ID: 12084323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
    Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
    Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A scientific basis for the therapeutic effects of Pygeum africanum and Serenoa repens.
    Levin RM; Das AK
    Urol Res; 2000 Jun; 28(3):201-9. PubMed ID: 10929430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of phytotherapy on utility scores for 5 benign prostatic hyperplasia/lower urinary tract symptoms health states.
    Dedhia RC; Calhoun E; McVary KT
    J Urol; 2008 Jan; 179(1):220-5. PubMed ID: 18001791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
    Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
    J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do we know about phytotherapy of benign prostatic hyperplasia?
    Allkanjari O; Vitalone A
    Life Sci; 2015 Apr; 126():42-56. PubMed ID: 25703069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary and alternative medications for benign prostatic hyperplasia.
    Keehn A; Lowe FC
    Can J Urol; 2015 Oct; 22 Suppl 1():18-23. PubMed ID: 26497340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents.
    Azimi H; Khakshur AA; Aghdasi I; Fallah-Tafti M; Abdollahi M
    Inflamm Allergy Drug Targets; 2012 Jun; 11(3):207-21. PubMed ID: 22512478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
    Dreikorn K; Schönhöfer PS
    Urologe A; 1995 Mar; 34(2):119-29. PubMed ID: 7538709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cernilton for benign prostatic hyperplasia.
    Wilt T; Mac Donald R; Ishani A; Rutks I; Stark G
    Cochrane Database Syst Rev; 2000; (2):CD001042. PubMed ID: 10796739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a nanocomposite containing Orbignya speciosa lipophilic extract on Benign Prostatic Hyperplasia.
    de Souza PA; Palumbo A; Alves LM; de Souza VP; Cabral LM; Fernandes PD; Takiya CM; Menezes FS; Nasciutti LE
    J Ethnopharmacol; 2011 Apr; 135(1):135-46. PubMed ID: 21396436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol Extract of
    Park E; Lee MY; Seo CS; Jang JH; Kim YU; Shin HK
    Nutrients; 2018 Apr; 10(4):. PubMed ID: 29690562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
    Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK
    J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.